Home / Cancer and immune system / Lenalidomide
ATC L04AX04 · Immunosuppressants
Lenalidomide shortage
As of 31 Oct 2026, Lenalidomide has a reported shortage in 4 of the 5 countries we track (Italy, Spain, Austria, Belgium), covering 36 products.
Countries4/5
Products36packs or presentations
Short since26 Jun 20242.3 years ago
Earliest return12 Nov 2026company estimate
No return date16products
Main reasonManufacturing problem
Timeline
ItalySpainAustriaBelgium
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Affected products
| Country | Product | Holder | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IT | LENALIDOMIDE KRKA | KRKA D.D. NOVO MESTO | 11 Jul 2024 | not given | Increased demand Elevata richiesta |
| IT | LENALIDOMIDE KRKA | KRKA D.D. NOVO MESTO | 11 Jul 2024 | not given | Increased demand Elevata richiesta |
| IT | LENALIDOMIDE KRKA | KRKA D.D. NOVO MESTO | 15 Jul 2024 | not given | Increased demand Elevata richiesta |
| IT | LENALIDOMIDE MYLAN | MYLAN PHARMACEUTICALS LIMITED | 1 Oct 2025 | not given | Manufacturing problem Problemi produttivi |
| IT | LENALIDOMIDE ACCORD | ACCORD HEALTHCARE, S.L.U. | 24 Apr 2026 | not given | Increased demand Elevata richiesta |
| IT | LENALIDOMIDE MYLAN | MYLAN PHARMACEUTICALS LIMITED | 8 May 2026 | not given | Manufacturing problem Problemi produttivi |
| IT | LENALIDOMIDE GRINDEKS | AS GRINDEKS | 15 May 2026 | not given | Increased demand Elevata richiesta |
| IT | LENALIDOMIDE SUN | SUN PHARMACEUTICAL INDUSTRIES (EUROPE) B.V. | 14 Jul 2026 | not given | Increased demand Elevata richiesta/problemi produttivi |
| IT | LENALIDOMIDE MYLAN | MYLAN PHARMACEUTICALS LIMITED | 28 Jul 2026 | not given | Manufacturing problem Problemi produttivi |
| IT | LENALIDOMIDE SUN | SUN PHARMACEUTICAL INDUSTRIES (EUROPE) B.V. | 25 Aug 2026 | not given | Increased demand Elevata richiesta |
| IT | LENALIDOMIDE SUN | SUN PHARMACEUTICAL INDUSTRIES (EUROPE) B.V. | 25 Sep 2026 | not given | Increased demand Elevata richiesta |
| IT | LENALIDOMIDE MYLAN | MYLAN PHARMACEUTICALS LIMITED | 5 Oct 2026 | not given | Manufacturing problem Problemi produttivi |
| IT | LENALIDOMIDE OLPHA | OLPHA AS | 18 Oct 2026 | 29 Mar 2027 | Manufacturing problem Problemi produttivi |
| IT | LENALIDOMIDE SUN | SUN PHARMACEUTICAL INDUSTRIES (EUROPE) B.V. | 28 Oct 2026 | not given | Increased demand Elevata richiesta |
| IT | LENALIDOMIDE ACCORD | ACCORD HEALTHCARE, S.L.U. | 31 Oct 2026 | not given | Commercial decision or withdrawal Motivi commerciali |
| IT | LENALIDOMIDE MYLAN announced | MYLAN PHARMACEUTICALS LIMITED | 5 Nov 2026 | not given | Manufacturing problem Problemi produttivi |
| IT | LENALIDOMIDE OLPHA announced | OLPHA AS | 29 Dec 2026 | 29 Mar 2027 | Manufacturing problem Problemi produttivi |
| IT | LENALIDOMIDE OLPHA announced | OLPHA AS | 29 Dec 2026 | 29 Mar 2027 | Manufacturing problem Problemi produttivi |
| IT | LENALIDOMIDE OLPHA announced | OLPHA AS | 29 Dec 2026 | 29 Mar 2027 | Manufacturing problem Problemi produttivi |
| ES | LENALIDOMIDA KRKA 10 mg CAPSULAS DURAS EFG, 21 capsulas | Krka D.D. Novo Mesto | 26 Nov 2024 | 28 Dec 2026 | Not stated |
| ES | LENALIDOMIDA KRKA 15 MG CAPSULAS DURAS EFG, 21 cápsulas | Krka D.D. Novo Mesto | 26 Nov 2024 | 28 Dec 2026 | Not stated |
| ES | LENALIDOMIDA KRKA 20 MG CAPSULAS DURAS EFG, 21 cápsulas | Krka D.D. Novo Mesto | 26 Nov 2024 | 28 Dec 2026 | Not stated |
| ES | LENALIDOMIDA KRKA 25 MG CAPSULAS DURAS EFG, 21 cápsulas | Krka D.D. Novo Mesto | 26 Nov 2024 | 28 Dec 2026 | Not stated |
| ES | LENALIDOMIDA KRKA 5 MG CÁPSULAS DURAS EFG, 21 capsulas | Krka D.D. Novo Mesto | 26 Nov 2024 | 28 Dec 2026 | Not stated |
| ES | LENALIDOMIDA SUN 20 MG CAPSULAS DURAS EFG , 21 cápsulas | Sun Pharmaceutical Industries (Europe) B.V. | 2 Jul 2026 | 14 Feb 2027 | Not stated |
| ES | LENALIDOMIDA KERN PHARMA 2,5 MG CAPSULAS DURAS EFG, 21 cápsulas | Kern Pharma S.L. | 31 Jul 2026 | not given | Not stated |
| ES | LENALIDOMIDA ACCORD 20 MG CAPSULAS DURAS EFG, 21 cápsulas | Accord Healthcare S.L.U. | 3 Aug 2026 | 14 Nov 2026 | Not stated |
| ES | LENALIDOMIDA KERN PHARMA 20 MG CAPSULAS DURAS EFG, 21 cápsulas | Kern Pharma S.L. | 31 Aug 2026 | 12 Nov 2026 | Not stated |
| ES | LENALIDOMIDA TEVA 20 MG CAPSULAS DURAS EFG, 21 cápsulas | Teva B.V. | 16 Sep 2026 | 14 Jan 2027 | Not stated |
| AT | Lenalidomid Krka 2,5 mg Hartkapseln, 21 Stück | KRKA d.d. Novo Mesto | 12 May 2026 | 30 Nov 2026 | Manufacturing problem Verzögerung bei der Herstellung |
| AT | Lenalidomid Krka 7,5 mg Hartkapseln, 21 Stück | KRKA d.d. Novo Mesto | 23 Jul 2026 | 15 Nov 2026 | Manufacturing problem Verzögerung bei der Herstellung |
| AT | Lenalidomid Zentiva 5 mg Hartkapseln, 21 Stück | Zentiva k.s. | 16 Sep 2026 | 15 Dec 2026 | Manufacturing problem Verzögerung bei der Herstellung |
| BE | Lenalidomide Accord 2.5 mg hard caps. 21 (21 x 1) UD | Accord Healthcare | 26 Jun 2024 | 16 Nov 2026 | Manufacturing problem Delay in production |
| BE | Revlimid 5 mg (Abacus Medicine) hard caps. 21 | Bristol-Myers Squibb Pharma | 4 Sep 2026 | 31 Aug 2027 | Other Other reason |
| BE | Lenalidomide Accord 10 mg hard caps. 21 (21 x 1) UD | Accord Healthcare | 28 Sep 2026 | 30 Jan 2027 | Manufacturing problem Delay in production |
| BE | Lenalidomide Accord 5 mg hard caps. 21 (21 x 1) UD | Accord Healthcare | 28 Sep 2026 | 31 Jan 2027 | Manufacturing problem Delay in production |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.